Name: Cytosorbents Corporation (CTSO) Balance Sheet
Creator: FinSpry

Cytosorbents Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cytosorbents Corporation (CTSO) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	3.28	14.13	22.14	52.14	71.42	12.23	22.37
Cash & Short-Term Investments	3.28	14.13	22.14	52.14	71.42	12.23	22.37
Accounts Receivable	7.32	6.06	5.66	4.52	5.16	4.47	3.94
Inventory	2.73	3.68	3.46	4.77	2.67	2.11	0.83
Other Current Assets	3.27	2.10	2.49	2.87	3.20	0.00	0.00
Total Current Assets	21.60	25.70	33.76	64.30	82.45	20.90	28.26
Non-Current Assets
Property, Plant & Equipment (Net)	20.51	22.12	23.35	18.57	3.15	3.00	3.18
Intangible Assets	3.75	3.91	4.39	4.70	4.22	0.00	0.00
Other Non-Current Assets	1.48	5.44	6.12	1.69	0.13	3.48	0.00
Total Non-Current Assets	25.77	27.56	29.47	25.22	7.50	6.48	5.93
Total Assets	47.37	53.26	63.23	89.52	89.95	27.38	34.20
Current Liabilities
Accounts Payable	3.34	3.80	1.66	3.85	1.84	2.04	5.87
Short-Term Debt	0.45	2.50	0.00	0.00	0.00	0.00	0.00
Current Portion of Long-Term Debt	0.00	2.50	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	4.75	4.99	6.43	7.11	7.14	0.00	0.00
Deferred Revenue	0.42	1.38	1.52	2.16	0.73	0.00	0.00
Other Current Liabilities	0.87	7.87	7.95	10.31	7.87	5.80	0.00
Total Current Liabilities	9.82	14.55	9.71	13.69	10.15	9.94	6.92
Non-Current Liabilities
Long-Term Debt	14.00	15.44	18.14	13.25	0.58	14.03	10.35
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	26.44	15.44	18.14	13.25	0.58	14.03	10.35
Total Liabilities	36.26	29.99	27.86	26.94	10.73	23.96	17.26
Stockholders' Equity
Common Stock	0.05	0.05	0.04	0.04	0.04	0.00	0.00
Retained Earnings	-304.01	-281.98	-251.67	-221.19	-196.63	-188.79	-169.52
Accumulated Other Comprehensive Income	4.25	0.53	2.33	0.53	-1.73	0.53	0.29
Additional Paid-in Capital	310.81	305.20	287.00	283.19	277.53	191.65	186.14
Shares Outstanding	55.10	54.51	43.85	43.69	0.00	0.00	0.00
Total Stockholders' Equity	11.11	23.28	35.37	62.58	79.22	3.42	16.93
Total Liabilities & Equity	47.37	53.26	63.23	89.52	89.95	27.38	34.20